Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Parkinson Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Quest Research Institute, Farmington Hills, Michigan, United States
Contact: Study coordinator (Tamsin Andres) · tamsin.andres@questri.com

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression

Parkinson s Disease · Parkinson Disease (PD)

Abroad (travel likely)RecruitingPHASE2

Arendal, Norway · Lørenskog, Norway

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Parkinson Disease · Dystonia · Essential Tremor

Abroad (travel likely)Recruiting

Cologne, Germany · Düsseldorf, Germany

Mobile Application for Gait Training in Parkinson's Disease

PARKINSON DIS

Abroad (travel likely)Recruiting

Izmir, Turkey (Türkiye)

Effects of Tai Chi Therapy Versus Qi-Gong in Stage-I Parkinson's Patients.

PARKINSON DISEASE (Disorder)

Abroad (travel likely)Recruiting

Lahore, Pakistan · Lahore, Pakistan